Table 5.
Study population by years of diagnosis
| Characteristic | 2000–2007 (n = 37) | 2008–2014 (n = 43) | P-value |
|---|---|---|---|
| Male, n (%) | 26 (70) | 38 (88) | 0.04 |
| Age, years, median (IQR) | 31 (23–41) | 30 (27–45) | 0.37 |
| Viral Load (log10 copies/ml), median (IQR) | 5.9 (4.9–6.3) | 5.2 (4.2–5.9) | 0.47 |
| CD4 (cells/mm3), median (IQR, n) | 396 (319–606, n = 29) | 431 (287–568, n = 21) | 0.8 |
| Risk group, n (%) | |||
| MSM | 20 (54.1) | 27 (62.8) | 0.49 |
| OGE | 14 (37.8) | 2 (4.7) | <0.05 |
| Other | 3 (8.1) | 14 (32.6) | <0.05 |
| Subtype, n (%) | |||
| B | 22 (59.5) | 26 (60.5) | 1 |
| C | 14 (37.8) | 3 (6.9) | <0.05 |
| A | 1 (2.7) | 10 (23.3) | <0.05 |
| G/AG/F | 0 | 4 (9.5) | 0.12 |
| SBS TDRM, n (%) | 1 (2.7) | 6 (13.9) | 0.12 |
| NGS TDRM, n (%) | 9 (24.3) | 16 (37.2) | 0.24 |
MSM – men who have sex with men; OGE – originating in countries with generalized epidemics; TDRM – transmitted drug resistance mutations; SBS – Sanger-based sequencing; NGS – next-generation sequencing.